While direct CD71–integrin binding in cancer remains under study, integrin trafficking/signaling is tightly coupled to clathrin/AP2 pathways that also handle CD71, providing a mechanistic intersection that can influence adhesion and the cytoskeleton [102]. The gene discussed is TFRC; the disease is cancer.